Skip to main content
Signal8

Weinberg Uri

SEC insider (Form 3/4/5 filer). CIK 0001811030. Chf Medical and Innovation Ofr at NovoCure Ltd (NVCR). 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in WAYNE, PA.

Companies Weinberg Uri has filed insider reports for

  • NovoCure Ltd (NVCR): Officer, Chf Medical and Innovation Ofr
Weinberg Uri profile photo

Weinberg Uri

CIK: 0001811030

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NovoCure Ltd logo
NVCR

NovoCure Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 4, 2026
    Sale
    Direct
    6.4K shares at avg. $13.31$85K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2026
    Award
    Direct
    50.1K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 2, 2026
    Sale
    Direct
    3.3K shares at avg. $13.33$44K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 28, 2026
    Award
    Direct
    13K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 27, 2026
    Sale
    Direct
    7.5K shares at avg. $13.84$103K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 4, 2025
    Award
    Direct
    55K shares at avg. $18.19$1000K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2025
    Sale
    Direct
    268 shares at avg. $18.92$5K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 28, 2025
    Sale
    Direct
    311 shares at avg. $18.31$6K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 28, 2025
    Sale
    Direct
    4.3K shares at avg. $18.78$81K

1-9 of 9